Former US president Ronald Reagan's diagnosis of Alzheimer's disease highlighted the fear and lack of understanding surrounding the illness. Alzheimer's is a growing crisis in countries like India, where millions are affected. The disease is often undiagnosed due to stigma and limited access to specialist care. The burden of caregiving falls heavily on families, often women. Confirming Alzheimer's has historically required expensive tests, leading to late diagnoses. Researchers have developed a blood test to predict the onset of Alzheimer's symptoms. This test measures the levels of the p-tau217 protein, which reflects changes in the brain associated with Alzheimer's. The test may help doctors counsel patients and families years before symptoms appear. Affordable blood tests could transform the landscape, enabling better planning and access to treatments. This shift offers hope for patients, families, and healthcare systems. The development of these tests marks a critical turning point towards early detection and prediction.